Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 6601 - 6608 of 12008 results
N.C.A.A.: North Carolina Will Not Be Punished for Academic Scandal
October 13, 2017| News
Exploring Wage Deductions in California, Massachusetts, New York and Washington, D.C.
October 12, 2017| Blog| Viewpoint
Chief Judge Stark Rejects Motion for Enhanced Damages Award Due to the Public Interest in the Accused Hepatitis C Virus Treatments
October 12, 2017| Blog| Viewpoint
After NYT Challenge, BuzzFeed Drops 'All The News' Slogan
October 12, 2017| News
Are Medicare Anti-Fraud Efforts Flawed?
October 12, 2017| News
New York Paid Family Leave Law – A Comprehensive Breakdown for Employers
October 11, 2017| Blog| Viewpoint
Can Employees Pay for Cord Blood Storage with an HRA, FSA or HSA?
October 11, 2017| Blog| Viewpoint
Association Health Plans—Can The Trump Administration Expand Access Without Congress?
October 11, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|